Myovant Sciences Ltd.

NYSE: MYOV · Real-Time Price · USD
26.98
-0.01 (-0.04%)
At close: Mar 09, 2023, 10:01 PM

Myovant Sciences Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2022 FY 2021
Period Ending Mar 31, 2022 Mar 31, 2021
Revenue
230.97M 59.32M
Cost of Revenue
51.55M 1.97M
Gross Profit
179.42M 57.35M
Operating Income
-187.35M -260.78M
Interest Income
384K 211K
Pretax Income
-200.93M -254.8M
Net Income
-205.98M -255.13M
Selling & General & Admin
259.36M 181.42M
Research & Development
107.4M 136.71M
Other Expenses
n/a 1.66M
Operating Expenses
366.77M 318.14M
Interest Expense
13.97M 10.4M
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
418.32M 320.1M
Income Tax Expense
5.05M 336K
Shares Outstanding (Basic)
92.97M 90.04M
Shares Outstanding (Diluted)
92.97M 90.04M
EPS (Basic)
-2.22 -2.83
EPS (Diluted)
-2.22 -2.83
EBITDA
-183.89M -258.09M
EBIT
-186.96M -244.4M
Depreciation & Amortization
3.07M 2.48M